The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

Completed · Phase 1 · Has a placebo group

Conditions studied: Mild Cognitive Impairment

In brief

This study is examining the effects of growth hormone releasing hormone (GHRH) on mild cognitive impairment (MCI). GHRH will be given at a dose of 1mg/day for 10 weeks to subjects with MCI as well as healthy controls.

Key facts

Study ID
NCT02553603
Run by
The University of Texas Medical Branch, Galveston
People needed
22
Starts
2017-07-18
Expected to finish
2019-01-17
Last updated by the study team
2019-11-04

Who can join

Age: 55 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.